679 related articles for article (PubMed ID: 17729066)
1. Dyspnea and activity limitation in COPD: mechanical factors.
O'Donnell DE; Laveneziana P
COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
[TBL] [Abstract][Full Text] [Related]
2. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease.
Laveneziana P; Parker CM; O'Donnell DE
Appl Physiol Nutr Metab; 2007 Dec; 32(6):1225-38. PubMed ID: 18059601
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of dyspnea in chronic lung disease.
Rock LK; Schwartzstein RM
Curr Opin Support Palliat Care; 2007 Aug; 1(2):102-8. PubMed ID: 18685350
[TBL] [Abstract][Full Text] [Related]
4. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation.
Pepin V; Saey D; Laviolette L; Maltais F
COPD; 2007 Sep; 4(3):195-204. PubMed ID: 17729063
[TBL] [Abstract][Full Text] [Related]
5. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
6. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
O'Donnell DE
Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
[TBL] [Abstract][Full Text] [Related]
8. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
[TBL] [Abstract][Full Text] [Related]
9. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
11. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
12. [Importance of air-trapping in patients with COPD. Pathophysiological principle].
Voshaar TH
Med Klin (Munich); 2005 Oct; 100 Suppl 1():5-8. PubMed ID: 16422211
[TBL] [Abstract][Full Text] [Related]
13. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms to dyspnoea and dynamic hyperinflation related exercise intolerance in COPD.
Varga J
Acta Physiol Hung; 2015 Jun; 102(2):163-75. PubMed ID: 26100306
[TBL] [Abstract][Full Text] [Related]
15. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.
Langer D; Ciavaglia CE; Neder JA; Webb KA; O'Donnell DE
Expert Rev Respir Med; 2014 Dec; 8(6):731-49. PubMed ID: 25159007
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).
Grazzini M; Stendardi L; Gigliotti F; Scano G
Respir Med; 2005 Nov; 99(11):1403-12. PubMed ID: 16210095
[TBL] [Abstract][Full Text] [Related]
17. Airflow obstruction and exercise.
Cooper CB
Respir Med; 2009 Mar; 103(3):325-34. PubMed ID: 19071004
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
